Ní Leathlobhair, Máire https://orcid.org/0000-0002-8523-4935
Frangou, Anna https://orcid.org/0000-0001-6990-2756
Kinnersley, Ben https://orcid.org/0000-0003-1783-6296
Cornish, Alex J. https://orcid.org/0000-0002-3966-3501
Chubb, Daniel
Lakatos, Eszter https://orcid.org/0000-0002-7221-6850
Arumugam, Prabhu
Gruber, Andreas J. https://orcid.org/0000-0001-7664-4257
Law, Philip https://orcid.org/0000-0001-9663-4611
Tapinos, Avraam
Jakobsdottir, G. Maria https://orcid.org/0000-0001-8225-6541
Peneva, Iliana
Sahli, Atef
Smyth, Evie M. https://orcid.org/0009-0004-8653-3285
Ball, Richard Y. https://orcid.org/0000-0003-0579-3911
Sylva, Rushan
Benes, Ksenija
Stark, Dan
Young, Robin J.
Lee, Alexander T. J.
Wolverson, Vincent
Houlston, Richard S. https://orcid.org/0000-0002-5268-0242
Sosinsky, Alona https://orcid.org/0000-0001-9022-7409
Protheroe, Andrew https://orcid.org/0000-0001-9413-0575
Murray, Matthew J. https://orcid.org/0000-0002-4480-1147
Wedge, David C. https://orcid.org/0000-0002-7572-3196
Verrill, Clare https://orcid.org/0000-0002-4905-8233
,
,
Article History
Received: 16 March 2023
Accepted: 3 October 2024
First Online: 26 October 2024
Competing interests
: Genomics England is a company wholly owned by the UK Department of Health and Social Care and was created in 2013 to introduce WGS into healthcare in conjunction with NHS England. Authors affiliated with Genomics England are, or were, salaried by or seconded to Genomics England (A. Sosinsky, P.A.) or act as a GeCIP-specific patient/participant representative (V.W.). All other authors declare they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.